|
HUS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.179400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.036000E-02 |
| Normal-vs-Stage2 |
2.444800E-01 |
| Normal-vs-Stage3 |
1.9775299999969E-05 |
| Normal-vs-Stage4 |
3.556200E-03 |
| Stage1-vs-Stage2 |
9.469400E-01 |
| Stage1-vs-Stage3 |
4.481600E-03 |
| Stage1-vs-Stage4 |
1.317040E-01 |
| Stage2-vs-Stage3 |
7.561800E-02 |
| Stage2-vs-Stage4 |
3.128000E-01 |
| Stage3-vs-Stage4 |
4.139200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.777100E-04 |
| Normal-vs-AfricanAmerican |
7.68720000000611E-05 |
| Normal-vs-Asian |
9.460200E-01 |
| Caucasian-vs-AfricanAmerican |
3.016200E-02 |
| Caucasian-vs-Asian |
3.649400E-01 |
| AfricanAmerican-vs-Asian |
9.018300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.981000E-04 |
| Normal-vs-Female |
1.424220E-03 |
| Male-vs-Female |
9.554800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.710000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.516420E-02 |
| Normal-vs-Age(61-80Yrs) |
1.214930E-04 |
| Normal-vs-Age(81-100Yrs) |
2.901600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.756400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.056200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.816200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.772750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.301700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.929000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.298200E-01 |
| Normal-vs-Grade 2 |
1.395970E-02 |
| Normal-vs-Grade 3 |
1.575060E-04 |
| Normal-vs-Grade 4 |
4.570700E-04 |
| Grade 1-vs-Grade 2 |
1.738230E-01 |
| Grade 1-vs-Grade 3 |
8.174000E-02 |
| Grade 1-vs-Grade 4 |
5.124100E-02 |
| Grade 2-vs-Grade 3 |
8.297800E-02 |
| Grade 2-vs-Grade 4 |
3.829700E-02 |
| Grade 3-vs-Grade 4 |
3.603800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.301600E-02 |
| Normal-vs-ccB subtype |
2.596100E-02 |
| ccA subtype-vs-ccB subtype |
5.220200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.923600E-03 |
| Normal-vs-N1 |
2.599600E-01 |
| N0-vs-N1 |
6.488400E-01 |
|
|
